Mylan NV
www.mylan.com
Latest From Mylan NV
Teva To Launch First Generic EpiPen In 'Coming Months'; FDA Heralds Approval Of Complex Product
Two-and-a-half years after receiving a complete response letter, Teva's ANDA clears FDA; agency issued three guidances for development of generic epinephrine auto-injectors.
Enthusiasm For US Biosimilars Wanes For Some, But Not Others
Three years after the first biosimilar launched in the US, the market has failed to deliver notable return on investments. Some players like Mylan are going public with frustrations over market barriers, while others, like Amgen, say they are encouraged by steady progress. Teva, however, is limiting its investment in biosimilars.
Biosimilar Litigation Trends: Settlements, Declaratory Judgment Rejections, Congressional Intervention
Of the 27 suits brought so far, four have resulted in patent settlements; restarting patent dance is new trend for ongoing litigation.
Legality Of J&J's Remicade Contracting Depends On Share Of Biosimilar Market Foreclosed, Court Rules
Court denies J&J's motion to dismiss Pfizer's antitrust suit, saying discovery will reveal whether Pfizer has offered more competitive pricing for its Inflectra biosimilar and if there are alternative causes for Pfizer's inability to gain market share.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
- Generic Drugs
-
Drug Delivery
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Mylan Laboratories Inc.
- Mylan Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Parent & Subsidiaries
-
Mylan NV
- Agila Specialties Pvt. Ltd.
- Alphapharm Pty. Ltd.
- Dow Hickam Pharmaceuticals
- Meda AB
- Merck Generics Group
- Mylan Bertek Pharmaceuticals Inc.
- Mylan Institutional
- Mylan Laboratories Ltd.
- Mylan Pharmaceuticals Inc.
- Mylan Pharmaceuticals Pvt. Ltd.
- Mylan Specialty LP
- Mylan Technologies Inc.
- Penederm Inc.
- Somerset Pharmaceuticals Inc.
- Senior Management
-
Heather Bresch, CEO
Ken D Parks, CFO
Anthony Mauro, Chief Commercial Officer - Contact Info
-
Mylan NV
Phone: 1707 853000
Bldg. 4, Trident Pl.
Mosquito Way
Hatfield, PA AL10 9UL
UK
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice